Electromed Keeps Growing While Wall Street Barely Notices Electromed (NASDAQ:ELMD) has defied industry trends for 15 consecutive quarters, a remarkable feat in an era where many small cap medical device companies struggle to maintain growth.
The company's success is largely fueled by its home care business, which continues to thrive while hospital based sales lag behind.
The contrast between Electromed's two revenue streams speaks to the broader challenges facing healthcare providers.